DIPEPTIDYL PEPTIDASE IV (DPP IV) INHIBITORS

Course overview

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS ARE A GROUP OF ANTIHYPERGLYCEMIC MEDICATIONS USED IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS, WHICH IS A SIGNIFICANT RISK FACTOR FOR CORONARY DISEASE, HEART FAILURE, STROKE, AND MANY OTHER CARDIOVASCULAR CONDITIONS. THIS ACTIVITY REVIEWS THE VARIOUS DRUGS IN THIS GROUP, INDICATIONS, CONTRAINDICATIONS, ACTIVITY, ADVERSE EVENTS, AND OTHER KEY ELEMENTS OF DPP-4 INHIBITORS THERAPY IN THE CLINICAL SETTING. IT ALSO ELABORATES ON THE ESSENTIAL INFORMATION NEEDED BY ANY MEMBER OF AN INTERPROFESSIONAL TEAM MANAGING THE CARE OF PATIENTS WITH DIABETES.